Burning Rock Biotech Limited — Form 6-K Summary
Reporting period and context: This Form 6-K was filed on November 7, 2022, for the month of November 2022, by Burning Rock Biotech Limited, a foreign private issuer headquartered in Guangzhou, China. The filing is administrative and does not report operating or financial results.
Financial and Operating Metrics
The filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, cash balances, operating metrics, or other financial performance measures.
Material Changes and Outlook
The filing does not disclose material changes versus a prior comparable period, management guidance, business outlook, risks, contingencies, or unusual items.
Registration Statement and Exhibits
- The report, including Exhibits 5.1 and 23.1, is incorporated by reference into the company’s Form F-3 registration statement, which became effective on September 30, 2022.
- Exhibit 5.1 is an opinion of Maples and Calder (Hong Kong) LLP.
- Exhibit 23.1 is the related consent of Maples and Calder (Hong Kong) LLP, included in Exhibit 5.1.
- The report was signed by Leo Li, Chief Financial Officer.
Investor Verification Points
- Verify the related Form F-3 registration statement and the legal opinion incorporated by reference.
- Review subsequent Form 6-K filings and the company’s Form 20-F for financial results, liquidity, risks, and business developments.
- Confirm the scope and effect of the incorporation by reference, including any later superseding filings.